Progressive myoclonic ataxia with intrathecal immune activation in six patients.
In six patients with slowly progressive sporadic cerebellar ataxia and cortical multifocal action myoclonus, cerebrospinal fluid (CSF) IgG index was persistently very high (1.2-6.7) and numerous oligoclonal bands were detected. Progressive cognitive impairment and MRI cerebellar and cerebral atrophy were observed. No serum antibodies were found. Various degenerative, metabolic, inflammatory and systemic diseases were excluded. The cerebellum may be the main target of a degenerative or immune process and releases antigens that, enhancing a compartmentalised (auto)immune response, as suggested by the persistent intrathecal activation, could lead to further cerebellar damage. As the frequency of CSF oligoclonal banding in myoclonic ataxia is unknown, our patients' disease might represent a hitherto unreported entity or a subset of progressive myoclonic ataxia.
Testa
D
D
Department of Neurology, Fondazione IRCCS Institute C. Besta, Via Celoria 11, I-20133, Milan, Italy. dtesta@istituto-besta.it
Ambrosoni
E
E
Franceschetti
S
S
Salmaggi
A
A
Soliveri
P
P
Girotti
F
F
D000328:Adult; D001259:Ataxia / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000276:immunology* / Q000503:physiopathology; D002490:Central Nervous System / Q000276:immunology*; D002531:Cerebellum / Q000473:pathology; D004569:Electroencephalography / Q000379:methods; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008875:Middle Aged; D009207:Myoclonus / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000276:immunology* / Q000503:physiopathology; D043025:Oligoclonal Bands / Q000134:cerebrospinal fluid
D043025:Oligoclonal Bands
Muscle Nerve. 2000 Mar;23(3):321-35
10679708
Curr Opin Neurol. 2003 Jun;16(3):267-73
12858061
N Engl J Med. 2003 Oct 16;349(16):1543-54
14561798
Scott Med J. 1957 May;2(5):200-15
13432835
Science. 2003 Oct 31;302(5646):834-8
14593170
Neurology. 2000 Mar 28;54(6):1350-6
10746609
Neurology. 2004 Dec 28;63(12):2309-15
15623692
Mov Disord. 1995 Jul;10(4):418-23
7565820
Mov Disord. 1995 Mar;10(2):207-10
7753063
Arch Neurol. 1981 Apr;38(4):206-8
6783017
Adv Neurol. 2005;96:275-83
16383226
Neurol Sci. 2002 Oct;23(4):145-51
12536283
Brain. 2002 May;125(Pt 5):961-8
11960886
Ann Neurol. 2005 Dec;58(6):840-6
16283615
Clin Neurophysiol. 2003 Jun;114(6):1041-52
12804673
Neurology. 2002 Apr 23;58(8):1221-6
11971090
Epilepsia. 2001 Mar;42(3):430-2
11442164
J Neurol Neurosurg Psychiatry. 1994 Dec;57(12):1510-7
7798982
J Neurol Sci. 1994 Jul;124 Suppl:14-9
7807136
Brain. 1994 Aug;117 ( Pt 4):759-65
7922463
Adv Neurol. 2002;89:31-4
11968458
Ann Neurol. 1983 Mar;13(3):227-31
6847134
J Neurol Neurosurg Psychiatry. 2006 Mar;77(3):345-50
16174651
J Neurol. 2004 Feb;251(2):184-8
14991353